§ The providers
Who sells what — and who to trust.

An independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.

View the provider overviewOverview & reviews
§ Learn
The educational layer, in progress.

Primers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.

View all Learn articles
503A · Fort Lauderdale, FL

Hallandale Pharmacy: 503A compounder profile

A large PCAB-accredited Florida 503A compounder with explicit compounded semaglutide/tirzepatide, peptides, and HRT — a leading telehealth-partner pharmacy.

Editorial independence

This profile is editorial. PeptideWellness has no commercial relationship with this pharmacy; coverage and assessment are never for sale.

Hallandale is one of the larger consumer-facing 503A compounders — the kind of patient-specific pharmacy that fills prescriptions routed through telehealth practices. It’s a 503A (state-regulated, patient-specific), not a 503B outsourcing facility.

Facility & accreditation

Hallandale operates as a 503A pharmacy (legal entity “Pharmcore, LLC” dba Hallandale Pharmacy, Fort Lauderdale, FL); it is not on the FDA 503B outsourcing-facility list [3]. We independently confirmed its PCAB accreditation in ACHC’s own directory — listed under Pharmcore / Hallandale Pharmacy, Fort Lauderdale, FL, PCAB Compounding Pharmacy [2]. The company says it has operated since 2003 from a ~60,000-sq-ft facility, working with thousands of practitioners and shipping nationwide [1].

What they compound

Explicitly on-audience: weight management with compounded semaglutide (2.5 and 5 mg/mL) and tirzepatide (10 and 15 mg/mL), a dedicated peptide-therapy line, hormone replacement, sexual wellness, dermatology, fertility, and IV therapy [1].

Regulatory record

As a 503A pharmacy, Hallandale’s primary oversight is Florida’s board of pharmacy rather than FDA CGMP inspection, so there is less federal paper trail. We found no FDA warning letter for Hallandale/Pharmcore in public sources, and it does not appear on the FDA 503B list [3]. As always with 503A, absence from federal databases is not an exhaustive clean record.

The read

Among the strongest “pure 503A telehealth-partner” options in the set: PCAB-accredited (independently confirmed), explicit compounded GLP-1 and peptide lines, long operating history, national reach. The 503A model means state-board oversight rather than FDA CGMP — the standard trade-off versus a 503B like Empower.

References

  1. Hallandale Pharmacy — official site. https://hallandalerx.com/ (accessed 2026-07-01)
  2. ACHC / PCAB accredited-organization directory (listed as Pharmcore / Hallandale Pharmacy, Fort Lauderdale, FL). https://organization.achc.org/ (accessed 2026-07-01)
  3. FDA — Registered Outsourcing Facilities (503B) list (Hallandale not listed → confirms 503A). https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities (accessed 2026-07-01)
§ The Daily

The peptide brief, delivered.

A 5-minute daily digest on peptide therapy news, provider updates, and regulatory changes.

Find your peptide Take 60-sec quiz